InvestorNewsBreaks

Thursday Feb 12, 2026 - 2:46 pm

InvestorNewsBreaks – Xeriant Inc. (XERI) Positions Factor X at Forefront of Advanced Research Under Brig. Gen. Holt

Xeriant (OTCQB: XERI) recently expanded the role of Brig. Gen. Blaine D. Holt (ret.), signaling a deeper commitment to disciplined innovation and advanced research. An article discussing this reads, “Holt’s appointment to lead Factor X marked the beginning of his formal involvement with Xeriant and expanded his responsibilities beyond advisory into active leadership of the company’s most forward-looking research initiatives. Xeriant recognized that Holt’s experience…

Thursday Feb 12, 2026 - 1:14 pm

InvestorNewsBreaks – Roth Capital Partners Expands Healthcare Platform with Three Senior Hires

Roth Capital Partners announced the addition of Jack Terranova as Managing Director, Healthcare Investment Banking, Noah Huehnergarth as Executive Director, Institutional Sales, and Max Masucci as Managing Director and Senior Research Analyst, further strengthening its healthcare platform across investment banking, institutional sales, and equity research. The firm stated the hires enhance its integrated, sector-focused capabilities in life sciences, diagnostics, and therapeutics, supporting capital markets execution, investor connectivity, and strategic growth initiatives, as…

Thursday Feb 12, 2026 - 12:49 pm

InvestorNewsBreaks – Sonim Technologies (NASDAQ: SONM) Renames to DNA X, Inc. Following Asset Sale to NEXA(R)

Sonim Technologies (NASDAQ: SONM) changed its corporate name to DNA X, Inc. concurrent with its previously announced asset sale to NEXA(R) formerly Social Mobile. The company stated proceeds from the transaction are expected to fund debt retirement and provide working capital for its digital asset management operations, with DNA X, Inc. moving forward as operator of the DNA X digital asset trading platform acquired in December 2025. The company will temporarily…

Thursday Feb 12, 2026 - 9:45 am

InvestorNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) Receives Positive DSMB Recommendation to Continue Phase 3 Alzheimer’s Trial

Annovis Bio (NYSE: ANVS) announced that an independent Data and Safety Monitoring Board has issued a positive recommendation supporting continuation of its ongoing pivotal Phase 3 Alzheimer’s disease clinical trial of buntanetap without modification following a 6-month safety review. The DSMB found no safety concerns after evaluating unmasked data, with safety outcomes in Alzheimer’s patients consistent with those observed in Parkinson’s patients at the same time point, and additional safety reviews planned…

Thursday Feb 12, 2026 - 9:45 am

InvestorNewsBreaks – SOLOWIN HOLDINGS (NASDAQ: AXG) Secures Up to $100 Million Financing Agreement with Streeterville Capital

SOLOWIN HOLDINGS (NASDAQ: AXG) announced it has entered into a securities purchase agreement with Streeterville Capital, LLC for up to $100 million in financing through the issuance of one or more pre-paid purchases for AXG class A ordinary shares. The company completed an initial pre-paid purchase of approximately $5.415 million before discounts and expenses, with additional purchases subject to mutual consent. Proceeds are expected to…

Thursday Feb 12, 2026 - 9:35 am

InvestorNewsBreaks – SuperCom Ltd. (NASDAQ: SPCB) Expands into Louisiana with New Electronic Monitoring Service Provider Contract

SuperCom (NASDAQ: SPCB) announced a new electronic monitoring service provider contract in Louisiana, marking its entry into its 16th new U.S. state and 17th new service provider partnership since mid-2024. Under the agreement, SuperCom will serve as the primary EM technology partner for a Louisiana-based provider operating statewide supervision programs, transitioning existing GPS tracking operations to its proprietary PureSecurity(TM) platform under a recurring revenue model…

Thursday Feb 12, 2026 - 9:30 am

InvestorNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Expands Global Intellectual Property Portfolio Supporting OT-101 Across Neurology and CNS Delivery

Oncotelic Therapeutics (OTCQB: OTLC) and Sapu Bioscience announced key advancements in their global intellectual property portfolio supporting OT-101, a proprietary TGF-β antisense therapeutic platform, with allowed patent claims in Australia covering OT-101 (SEQ ID NO:9) for the treatment of Parkinson’s Disease, including associated sleep-related symptoms, and granted utility model patents in China and Germany for an intracranial continuous infusion delivery device. The company stated the expanded protection spans therapeutic…

Thursday Feb 12, 2026 - 9:29 am

InvestorNewsBreaks – Renewal Fuels, Inc. (OTC: RNWF) Appoints Dwight Cartwright as Chief Operating Officer and Director

Renewal Fuels (OTC: RNWF) announced the appointment of Dwight Cartwright as Chief Operating Officer and member of its Board of Directors, strengthening leadership as the company advances the Texatron(TM) fusion platform toward commercial deployment. Cartwright brings senior experience across operations, manufacturing, infrastructure development and large-scale, technology-driven organizations, and will oversee day-to-day operations, manufacturing and supply chain readiness, infrastructure buildout, safety and quality systems, and organizational execution. Leadership highlighted his…

Thursday Feb 12, 2026 - 9:20 am

InvestorNewsBreaks – NanoViricides (NYSE American: NNVC) Files Orphan Drug Designation Application for NV-387 in MPox

NanoViricides, Inc. (NYSE American: NNVC) announced it has filed an application for Orphan Drug Designation for NV-387 as a treatment for MPox with the U.S. FDA Office of Orphan Products Development. If granted, the designation would provide incentives including tax credits for qualified clinical trials, exemption from certain user fees and potential seven years of market exclusivity following approval. The company highlighted ongoing global MPox…

Thursday Feb 12, 2026 - 9:05 am

InvestorNewsBreaks – Soligenix Inc. (NASDAQ: SNGX) CEO Highlights 2026 Clinical Milestones and Strategic Options

Soligenix (NASDAQ: SNGX) issued a shareholder update from President and CEO Dr. Christopher J. Schaber outlining anticipated 2026 milestones across its late-stage rare disease pipeline, including top-line data from the Phase 3 FLASH2 trial of HyBryte™ in early-stage cutaneous T-cell lymphoma expected in the second half of 2026, with an interim analysis approaching in the second quarter and 66 of 80 patients enrolled as of Feb. 10. The…

Thursday Feb 12, 2026 - 9:00 am

InvestorNewsBreaks – New Pacific Metals Corp. (TSX: NUAG) (NYSE American: NEWP) Reports Fiscal 2026 Second Quarter Results and $41 Million Working Capital

This article has been disseminated on behalf of New Pacific Metals Corp. and may include paid advertising. New Pacific Metals (TSX: NUAG) (NYSE American: NEWP) reported a net loss attributable to equity holders of $1.58 million, or $0.01 per share, for the three months ended Dec. 31, 2025, and $2.33 million, or $0.01 per share, for the six months ended Dec. 31, 2025, compared with a net loss of $0.74…

Thursday Feb 12, 2026 - 9:00 am

InvestorNewsBreaks – Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Schedules 2025 Financial Results Conference Call for Feb. 27

This article has been disseminated on behalf of Energy Fuels Inc. and may include paid advertising. Energy Fuels (NYSE American: UUUU) (TSX: EFR) a U.S.-based uranium and rare earth elements producer, will host a conference call and webcast on Friday, Feb. 27, 2026, at 9 a.m. Mountain Time to discuss its financial results for 2025. Management will lead the session followed by a question-and-answer period,…

Wednesday Feb 11, 2026 - 3:51 pm

InvestorNewsBreaks – Numa Numa Resources Inc. Poised as Copper Supply Tightens, Prices Rise

Disseminated on behalf of Numa Numa Resources Inc. and may include paid advertisements. Numa Numa Resources is positioned for opportunity amid acceleration of global copper demand as electrification, infrastructure expansion and critical technological developments strain existing supplies. This “sets the stage for renewed interest in major copper projects such as those being advanced by Numa Numa Resources in Bougainville. As analysts forecast persistent deficits and structural demand…

Wednesday Feb 11, 2026 - 3:31 pm

InvestorNewsBreaks – GridAI Technologies Corp. (NASDAQ: GRDX) Highlights Growth Strategy at Intersection of AI and Power Management

GridAI Technologies (NASDAQ: GRDX) is focused on advancing opportunities at the intersection of artificial intelligence and energy infrastructure following its acquisition of Grid AI, Inc. “The company recently announced that it had named Marshall Chapin as the CEO of the company’s GridAI, Inc. subsidiary,” an article discussing the company reads. “GridAI, Inc. is developing next-generation grid and power-management software for hyperscale artificial-intelligence (‘AI’) data-center campuses,…

Wednesday Feb 11, 2026 - 3:05 pm

InvestorNewsBreaks – Micropolis AI Robotics (NYSE American: MCRP) Debuts M01-Based Autonomous System for Industrial Use

Micropolis (NYSE American: MCRP) was featured in a recent article that discussed its efforts to expand its industrial robotics portfolio through unveiling a new platform designed for heavy-duty, continuous operations. “The platform was revealed in January at the UMEX 2026 exhibition in Abu Dhabi, where it was showcased on the stand of EDGE Group, the UAE’s state-backed advanced technology and defense manufacturer,” the publication reads.…

Wednesday Feb 11, 2026 - 2:46 pm

InvestorNewsBreaks – LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Bringing First-in-Class Approach to Chemo and Immunotherapy

LIXTE Biotechnology Holdings (NASDAQ: LIXT), a clinical-stage pharmaceutical company, is focused on enhancing established cancer therapies by targeting a fundamental biological pathway involved in tumor survival and resistance. “Rather than developing standalone treatments, LIXTE is advancing a first-in-class approach designed to increase the effectiveness of chemotherapy and immunotherapy across multiple cancer indications,” reads a recent article. “At the center of LIXTE’s strategy is protein phosphatase…

Wednesday Feb 11, 2026 - 1:50 pm

InvestorNewsBreaks – SPACSphere Acquisition Corp. (NASDAQ: SSACU) Closes $172.5 Million Initial Public Offering

SPACSphere Acquisition (NASDAQ: SSACU) announced the closing of its initial public offering of 17,250,000 units at $10.00 per unit, including 2,250,000 units issued pursuant to the full exercise of the underwriter’s over-allotment option, generating gross proceeds of $172.5 million. The units began trading on the Nasdaq Global Market on Feb. 6, 2026, under the symbol “SSACU,” with underlying Class A ordinary shares, warrants and share…

Wednesday Feb 11, 2026 - 1:32 pm

InvestorNewsBreaks – Datavault AI Inc. (NASDAQ: DVLT) Featured by RADIO + TELEVISION BUSINESS REPORT for ADIO Engagement Platform and Real-Time Bias Meter

Datavault AI (NASDAQ: DVLT) is highlighted in the Winter 2026 issue (p. 27) of RADIO + TELEVISION BUSINESS REPORT, which examines the company’s patented ADIO technology and real-time bias meter initiative. ADIO leverages embedded, inaudible audio signals to activate mobile viewer responses, enabling live polls, feedback and interactive engagement during broadcast and streamed programming. The publication points to the technology’s pilot deployment with Fintech.TV as an early stage proving ground ahead of broader rollout across streaming and broadcast platforms.…

Wednesday Feb 11, 2026 - 10:18 am

InvestorNewsBreaks – Wearable Devices Ltd. (NASDAQ: WLDS) Launches ai6 Labs to Advance Neural AI Ecosystem

Wearable Devices (NASDAQ: WLDS) announced the launch of ai6 Labs, a closed-loop ecosystem designed to bridge human intent with digital systems through non-invasive electromyography and its Mudra technology platform. The initiative integrates foundational neural research, commercialization and rapid AI experimentation through three pillars: a foundation layer built on the Large MUAP Model and Brain-AI Bus architecture to decode biological intent into machine-readable data; a revenue and ecosystem growth component aimed…

Wednesday Feb 11, 2026 - 10:05 am

InvestorNewsBreaks – Colombier Acquisition Corp. III (NYSE: CLBR U) Closes $299 Million Initial Public Offering

Colombier Acquisition (NYSE: CLBR U) announced the closing of its initial public offering of 29,900,000 units, including 3,900,000 units issued through the underwriters’ over-allotment option, at $10.00 per unit for total gross proceeds of $299 million. Each unit consists of one Class A ordinary share and one-eighth of one redeemable warrant, with whole warrants exercisable at $11.50 per share. The units trade on the New…

Wednesday Feb 11, 2026 - 9:30 am

InvestorNewsBreaks – Renewal Fuels, Inc. (OTC: RNWF) Engages IBN to Lead Corporate Communications Strategy Following American Fusion Repositioning

Renewal Fuels (OTC: RNWF), doing business as American Fusion, announced it has engaged IBN to support its corporate communications strategy following its completed merger with Kepler Fusion Technologies. The company has repositioned its operations toward the development and long-term commercialization of deployable fusion power systems for industrial and infrastructure applications, advancing its technology and deployment roadmap through a wholly owned subsidiary. Under the agreement, IBN will leverage its investor-focused…

Wednesday Feb 11, 2026 - 9:20 am

InvestorNewsBreaks – OptimumBank Holdings, Inc. (NYSE American: OPHC) to Host Feb. 18 Conference Call on Fourth-Quarter and Full-Year 2025 Results

OptimumBank Holdings (NYSE American: OPHC) announced that its management team will host a conference call and live webcast on Wednesday, Feb. 18, 2026, at 10 a.m. ET to discuss financial results for the fourth quarter and full year ended Dec. 31, 2025, and provide a business update. The company released its fourth-quarter and full-year earnings on Feb. 2, 2026, and invited current and prospective investors…

Wednesday Feb 11, 2026 - 9:10 am

InvestorNewsBreaks – Greenwave Technology Solutions Inc. (NASDAQ: GWAV) Appoints Chelsea Pullano as Chief Financial Officer

Greenwave Technology Solutions (NASDAQ: GWAV) announced that its board of directors appointed Chelsea Pullano as chief financial officer, effective Feb. 5, 2026. The appointment follows the company’s Jan. 2, 2026, scope of work agreement with MACK Financial Solutions LLC, under which MACK will provide bookkeeping, financial reporting and SEC reporting services, with Pullano serving as part-time CFO. Pullano, co-founder and CEO of MACK since May 2023,…

Wednesday Feb 11, 2026 - 9:05 am

InvestorNewsBreaks – Datavault AI Inc. (NASDAQ: DVLT) CEO Hosts Private Investor Dinner at Mar-a-Lago Following Strategic Engagements

Datavault AI (NASDAQ: DVLT) announced that Chief Executive Officer Nate Bradley hosted a private, invitation-only dinner Tuesday evening at Mar-a-Lago for institutional investors, high-net-worth individuals and senior government officials, following earlier meetings with a separate group of strategic investors. Discussions focused on the company’s execution roadmap, platform capabilities and long-term positioning in data infrastructure, digital engagement and real-world asset tokenization. The engagements follow recent visibility from Super Bowl LX weekend activations and a stockholder…

Wednesday Feb 11, 2026 - 9:00 am

InvestorNewsBreaks – Rail Vision Ltd. (NASDAQ: RVSN) Highlights 2025 Milestones, Strategic Partnerships and Quantum Expansion in CEO Update

Rail Vision (NASDAQ: RVSN) issued a corporate update from Chief Executive Officer David BenDavid outlining key 2025 milestones and strategic priorities for 2026. The company reported commercial advancements including a MainLine system order from a leading Central American freight operator, a $335,000 follow-on order from a Latin American mining company and expanded collaboration with Israel Railways, which highlighted Rail Vision’s AI technology at CES 2026. Rail Vision also announced a memorandum…

Wednesday Feb 11, 2026 - 9:00 am

InvestorNewsBreaks – From BCI to Endovascular Breakthroughs: Octane Showcases the Future of Neurotech

Octane, a Southern California innovation organization, will host its second annual Neuro Tech Forum on March 26–27, 2026, at the VEA Newport Beach. The two-day event is set to bring together investors, physicians, and industry leaders to explore emerging opportunities in neurotechnology. The forum lineup will feature keynote speaker Nick Hopkins, panel discussions on digital health, brain-computer interfaces (“BCI”), neuromodulation, neurovascular innovation, and treatments for…

Wednesday Feb 11, 2026 - 9:00 am

InvestorNewsBreaks – Nevada Organic Phosphate Inc. (CSE: NOP) (OTCQB: NOPFF) to Present Live Virtual Corporate Update Feb. 17

This article has been disseminated on behalf of Nevada Organic Phosphate Inc. and may include paid advertising. Nevada Organic Phosphate (CSE: NOP) (OTCQB: NOPFF) announced it will present a live virtual corporate update hosted by Existing Agency Inc. on Feb. 17 at 3 p.m. ET. Existing Agency invites current shareholders and interested parties to register for the webinar and participate in a live Q&A session following the presentation. A replay will be emailed to all registrants after the event and…

Tuesday Feb 10, 2026 - 11:42 am

InvestorNewsBreaks – Lantern Pharma (NASDAQ: LTRN) to Present AI-Driven Neuro-Oncology Strategy at Glioblastoma Summit

Lantern Pharma (NASDAQ: LTRN), a clinical-stage biopharmaceutical company leveraging artificial intelligence to accelerate oncology drug discovery and development, announced that Chief Executive Officer and President Panna Sharma will present at the 7th Glioblastoma Drug Development Summit, taking place Feb. 17–19, 2026, in Boston. During a Day Two presentation on Feb. 19, Mr. Sharma will highlight how the Company’s RADR® AI and machine learning platform supported the development of STAR-001,…

Tuesday Feb 10, 2026 - 11:25 am

InvestorNewsBreaks – MedWell Ai, Inc. (OTCQB: MWAI) Signs LOI to Form Vertically Integrated Health, Wellness and Longevity Platform

MedWell Ai (OTCQB: MWAI) announced that it has signed a letter of intent to create a vertically integrated health, wellness, and longevity platform organized across three core divisions: national pharma distribution and telemedicine, a nationwide portfolio of surgical, cosmetic, and men’s health centers, and an advanced biologics and product innovation group. The proposed consolidation includes Ageless Cosmetic Surgery Centers, Apollo BioWellness and its biologics subsidiary, and MedWell USA, with the combined company…

Tuesday Feb 10, 2026 - 11:25 am

InvestorNewsBreaks – Olenox Industries (NASDAQ: OLOX) Appoints Erik Blum and Adam Falkoff to Board of Directors

Olenox Industries (NASDAQ: OLOX) announced the appointment of Erik Blum and Adam Falkoff to its Board of Directors, effective Feb. 6, 2026. The appointments fill existing board vacancies, with both directors serving until the Company’s 2025 Annual Meeting of Shareholders and participating in the Company’s non-employee director compensation program, as Olenox adds leadership experience spanning public company turnarounds, corporate finance, public policy, and global strategic…

Tuesday Feb 10, 2026 - 11:24 am

InvestorNewsBreaks – Datavault AI Inc. (NASDAQ: DVLT) Showcases Live Data Monetization Platforms During Super Bowl LX Weekend

Datavault AI (NASDAQ: DVLT), a data monetization and digital engagement technology provider, announced the successful execution of multiple live activations during Super Bowl LX weekend, highlighted by a strategic partnership with NFL Alumni in Health and national Radio Row deployments. The Company demonstrated its proprietary ADIO(TM) data-over-sound platform, DVHOLO(TM) immersive visualization technology, and tokenized digital assets in real-world, high-traffic environments, validating their ability to capture, authenticate, and monetize audience…

Tuesday Feb 10, 2026 - 10:55 am

InvestorNewsBreaks – White Pearl Acquisition Corp. (NYSE: WPACU) Closes $115 Million Initial Public Offering

White Pearl Acquisition (NYSE: WPACU) announced that it closed its initial public offering on Feb. 3, 2026, issuing 11,500,000 units at $10.00 per unit, including 1,500,000 units sold pursuant to the full exercise of the underwriters’ over-allotment option. The units began trading on the New York Stock Exchange on Feb. 2, 2026, under the symbol “WPACU,” with each unit consisting of one Class A ordinary…

Tuesday Feb 10, 2026 - 10:30 am

InvestorNewsBreaks – NanoViricides (NYSE American: NNVC) Files Orphan Drug Designation Application for NV-387 as Measles Treatment

NanoViricides, Inc. (NYSE American: NNVC), a clinical-stage antiviral developer, announced that it has filed an application with the U.S. Food and Drug Administration Office of Orphan Products Development for Orphan Drug Designation for NV-387 as a treatment for measles. If granted, the designation would make the Company eligible for incentives including tax credits for qualified clinical trials, exemptions from certain FDA user fees, and up to…

Tuesday Feb 10, 2026 - 9:45 am

InvestorNewsBreaks – VolitionRx Limited (NYSE American: VNRX) Appoints MBL as Distributor for Nu.Q(R) Discover Assays in Japan

VolitionRx (NYSE American: VNRX), a multi-national epigenetics company, announced the appointment of Medical & Biological Laboratories Co. Ltd. as a non-exclusive distributor of its Nu.Q(R) Discover assays in Japan. The agreement expands access to Volition’s nucleosome-based biomarker assays for drug developers and researchers in the Japanese market and builds on the Company’s growing global collaborator network, as Nu.Q(R) Discover now serves close to 100 clients…

Tuesday Feb 10, 2026 - 9:30 am

InvestorNewsBreaks – Silvercorp Metals Inc. (TSX: SVM) (NYSE American: SVM) Reports Record Revenue and Cash Flow in Q3 Fiscal 2026

This article has been disseminated on behalf of Silvercorp Metals and may include paid advertising. Silvercorp Metals (TSX: SVM) (NYSE American: SVM) reported financial and operating results for the three months ended Dec. 31, 2025, delivering record quarterly revenue of $126.1 million, up 51% year over year, driven by higher realized silver and gold prices and steady silver equivalent production of approximately 2.0 million ounces. The Company generated record operating cash flow…

Tuesday Feb 10, 2026 - 9:20 am

InvestorNewsBreaks – Perpetuals.com Ltd (NASDAQ: PDC) Launches Barrier Futures Targeting Multi-Hundred-Trillion Derivatives Markets

Perpetuals.com (NASDAQ: PDC) announced the launch of Barrier Futures, a proprietary, MiFID II-compliant derivatives product designed as a regulated alternative to offshore perpetual futures and retail contracts for difference, addressing markets that collectively represent multi-hundred-trillion dollars in annual notional volume. The Company said Barrier Futures offer defined-risk positions without margin calls while enabling brokers to participate through a scalable B2B model that includes trading fee…

Tuesday Feb 10, 2026 - 9:15 am

InvestorNewsBreaks – Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF) Reports Additional High-Grade Drill Results at West Santa Fe

This article has been disseminated on behalf of Lahontan Gold Corp. and may include paid advertising. Lahontan Gold (TSX.V: LG) (OTCQB: LGCXF) announced additional analytical results from its 2025 maiden drilling program at the satellite West Santa Fe project in Nevada’s Walker Lane, reporting results from two reverse-circulation rotary drill holes that continue to validate historic drilling and demonstrate fault-controlled oxide gold and silver mineralization. Highlights include hole WSF25-03R intersecting 41.2 metres grading 1.94 g/t Au Eq, including 9.1 metres at 4.14…

Tuesday Feb 10, 2026 - 9:10 am

InvestorNewsBreaks – Helus Pharma(TM) (NASDAQ: HELP) (Cboe CA: HELP) Appoints Michael Cola as Chief Executive Officer

This article has been disseminated on behalf of Helus Pharma and may include paid advertising. Helus Pharma(TM) (NASDAQ: HELP) (Cboe CA: HELP), a clinical-stage pharmaceutical company developing novel serotonergic agonists to address serious mental health disorders, announced the appointment of Michael Cola as Chief Executive Officer, effective immediately, as the Company advances its pipeline toward key clinical and corporate milestones, including expected Phase 2 data for HLP004 this quarter and Phase 3 topline data for HLP003 in Q4 2026, while…

Tuesday Feb 10, 2026 - 9:10 am

InvestorNewsBreaks – Nevada Organic Phosphate Inc. (CSE: NOP; OTCQB: NOPFF) Reports Initial Assay Results from Murdock Mountain Property in Nevada

This article has been disseminated on behalf of Nevada Organic Phosphate Inc. and may include paid advertising. Nevada Organic Phosphate (CSE: NOP; OTCQB: NOPFF), a B.C.-based organic sedimentary phosphate explorer, announced continued progress interpreting assay results from the first six drill holes in the Upper Phosphatic Zone at Murdock Mountain, confirming a weighted average grade of 10.93% P₂O₅ supported by geochemical evidence showing the material…

Tuesday Feb 10, 2026 - 9:00 am

InvestorNewsBreaks – Forward Industries, Inc. (NASDAQ: FWDI) to Host Conference Call on First-Quarter 2026 Results Feb. 12

Forward Industries (NASDAQ: FWDI) the leading Solana treasury company, announced that it will host a conference call on Thursday, Feb. 12, 2026, at 5 p.m. Eastern Time to discuss its financial and operating results for the three months ended Dec. 31, 2025, with financial results to be released in a press release prior to the call; the Company’s executive team will host the call and webcast…

InvestorNewsBreaks

Get Started with InvestorWire

Press Distribution

Explore Press Distribution Solutions

Discover Add-on Solutions